These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8040109)

  • 1. Binding of teicoplanin and vancomycin to polymer surfaces.
    Wilcox MH; Winstanley TG; Spencer RC
    J Antimicrob Chemother; 1994 Mar; 33(3):431-41. PubMed ID: 8040109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD.
    Sanyal D; Johnson AP; George RC; Edwards R; Greenwood D
    J Antimicrob Chemother; 1993 Aug; 32(2):267-78. PubMed ID: 8226428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An electronmicroscope study of glycopeptide antibiotic-resistant strains of Staphylococcus epidermidis.
    Sanyal D; Greenwood D
    J Med Microbiol; 1993 Sep; 39(3):204-10. PubMed ID: 8366519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the selective binding of antibiotics vancomycin and teicoplanin by the VanS receptor regulating type A vancomycin resistance in the enterococci.
    Hughes CS; Longo E; Phillips-Jones MK; Hussain R
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1951-1959. PubMed ID: 28511809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
    Lee JG; Sagui C; Roland C
    J Am Chem Soc; 2004 Jul; 126(27):8384-5. PubMed ID: 15237988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anomalous growth of Staphylococcus epidermidis in the presence of Silastic and glycopeptide antibiotics.
    Hamilton-Miller JM; Shah S; Smith C
    FEMS Microbiol Lett; 1993 Oct; 113(2):145-7. PubMed ID: 8262364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel membrane proteins present in teicoplanin-resistant, vancomycin-sensitive, coagulase-negative Staphylococcus spp.
    O'Hare MD; Reynolds PE
    J Antimicrob Chemother; 1992 Dec; 30(6):753-68. PubMed ID: 1289350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.
    Biavasco F; Giovanetti E; Montanari MP; Lupidi R; Varaldo PE
    J Antimicrob Chemother; 1991 Jan; 27(1):71-9. PubMed ID: 1828799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics].
    Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K
    Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vancomycin, teicoplanin, and cefuroxime on Staphylococcus epidermidis adherence to intraocular lenses.
    Ozkan B; Karabaş VL; Gündeş S; Altintaş O; Etiler N; Cağlar Y
    J Cataract Refract Surg; 2005 Sep; 31(9):1814-20. PubMed ID: 16246789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
    J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro selection of resistance to vancomycin and teicoplanin in Enterococcus faecium and Enterococcus faecalis compared with Staphylococcus epidermidis.
    Markopulos E; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 1998 Jan; 41(1):43-7. PubMed ID: 9511036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin].
    Cohen R; Barre J; Varon E
    Pathol Biol (Paris); 1992 Oct; 40(8):831-44. PubMed ID: 1484744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of resistance to glycopeptide antibiotics in staphylococci.
    Biavasco F; Giovanetti E; Varaldo PE
    J Chemother; 1991 Jan; 3 Suppl 1():166-8. PubMed ID: 12041756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
    Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of glycopeptide antibiotics against coagulase-negative staphylococci embedded in fibrin clots.
    Cunningham R; Cheesbrough J
    J Antimicrob Chemother; 1992 Sep; 30(3):321-6. PubMed ID: 1452497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial teicoplanin dependence in a vancomycin-dependent Enterococcus faecium isolated from an oncology patient 1 month after cessation of teicoplanin therapy, Austria 2007.
    Huhulescu S; Schmid D; Mayer B; Stadlbauer S; Wewalka G; Allerberger F; Dworzak M
    Int J Antimicrob Agents; 2008 Jan; 31(1):86-8. PubMed ID: 18006277
    [No Abstract]   [Full Text] [Related]  

  • 18. vanA Gene Harboring Enterococcal and Non-enterococcal Isolates Expressing High Level Vancomycin and Teicoplanin Resistance Reservoired in Surface Waters.
    Nakipoğlu M; Yilmaz F; Icgen B
    Bull Environ Contam Toxicol; 2017 May; 98(5):712-719. PubMed ID: 27770152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association constants for the binding of vancomycin and teicoplanin to N-acetyl-D-alanyl-D-alanine and N-acetyl-D-alanyl-D-serine.
    Billot-Klein D; Blanot D; Gutmann L; van Heijenoort J
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):1021-2. PubMed ID: 7818465
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.